1. Home
  2. NPKI vs PHAR Comparison

NPKI vs PHAR Comparison

Compare NPKI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

HOLD

Current Price

$14.38

Market Cap

1.2B

Sector

Industrials

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$13.11

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPKI
PHAR
Founded
1932
1988
Country
United States
Netherlands
Employees
510
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NPKI
PHAR
Price
$14.38
$13.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$14.17
$38.33
AVG Volume (30 Days)
1.2M
5.1K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.39
$10.04
Revenue Next Year
$11.70
$2.51
P/E Ratio
$38.65
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$8.63
$9.54
52 Week High
$16.50
$21.34

Technical Indicators

Market Signals
Indicator
NPKI
PHAR
Relative Strength Index (RSI) 45.88 43.37
Support Level $14.18 $12.88
Resistance Level $15.17 $13.61
Average True Range (ATR) 0.56 0.47
MACD -0.02 -0.08
Stochastic Oscillator 34.18 13.92

Price Performance

Historical Comparison
NPKI
PHAR

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. It generates maximum revenue from United States.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: